510(k) · Cleared
Recalled · Class II · 2019RT Elements, Dose Review, Brain Metastases, Adaptive Hybrid Surgery Analysis
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Brainlab AG · MUJ System, Planning, Radiation Therapy Treatment
Cleared on Dec 16, 2014 as substantially equivalent to K103246 (Brainlab AG, 2011) after a 134-day review. Its family tree reaches back 6 generations to 1992. 5 later devices descend from it. It has been recalled 3 times.
- Decided
- Dec 16, 2014
- Review
- 134 days
- Class
- Class II
- Product code
- MUJ
- Recalls
- 3
- Predicates
- 1
Its longest line of descent runs back 6 generations to K920879 (1992). 16 ancestors in all. 5 later devices descend from it, 1 citing it directly.
- Root · 6 generations backK920879 Brainscan Radiosurgery ModuleBrainlab · 1992 · Recalled
- 5 generations backK994413 BrainscanBrainlab AG · 2000 · Recalled
- 4 generations backK032511 Intuition ImageBrainlab AG · 2004
- 3 generations backK052220 Iplan RT FibertrackingBrainlab AG · 2005
- 2 generations backK080886 Iplan RT ImageBrainlab AG · 2008
- 1 generation backK103246 Iplan RTBrainlab AG · 2011 · Recalled
- This deviceK142108 RT Elements, Dose Review, Brain Metastases, Adaptive Hybrid Surgery…Brainlab AG · 2014
- Descendant · cites it directly · 4 of its ownK202284 OncospaceOncospace, Inc. · 2021
- Descendant · 2 generations on · 3 of its ownK222803 OncospaceOncospace, Inc. · 2023
- Descendant · 3 generations on · 0 of its ownK253050 RadOncAIInformai · 2026
- Descendant · 3 generations on · 0 of its ownK250064 Dose+ (1.0)Mvision AI OY · 2025
- Descendant · 3 generations on · 0 of its ownK242748 OncospaceOncospace, Inc. · 2025
Most influential descendants
Showing 5 of 5 · See all- K202284OncospaceOncospace, Inc. · 2021 · cites it directly4descendants
- K222803OncospaceOncospace, Inc. · 2023 · 2 generations on3descendants
- K253050RadOncAIInformai · 2026 · 3 generations on0descendants
- K250064Dose+ (1.0)Mvision AI OY · 2025 · 3 generations on0descendants
- K242748OncospaceOncospace, Inc. · 2025 · 3 generations on0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −6 | K920879 | Brainscan Radiosurgery Module | Brainlab | 1992 | 1 |
| −5 | K994413 | Brainscan | Brainlab AG | 2000 | 1 |
| −4 | K032511 | Intuition Image | Brainlab AG | 2004 | — |
| −3 | K052220 | Iplan RT Fibertracking | Brainlab AG | 2005 | — |
| −2 | K080886 | Iplan RT Image | Brainlab AG | 2008 | — |
| −1 | K103246 | Iplan RT | Brainlab AG | 2011 | 2 |
| 0 (this device) | K142108 | RT Elements, Dose Review, Brain Metastases, Adaptive Hybrid Surgery Analysis | Brainlab AG | 2014 | — |
| +1 | K202284 | Oncospace | Oncospace, Inc. | 2021 | — |
| +2 | K222803 | Oncospace | Oncospace, Inc. | 2023 | — |
| +3 | K253050 | RadOncAI | Informai | 2026 | — |
| +3 | K250064 | Dose+ (1.0) | Mvision AI OY | 2025 | — |
| +3 | K242748 | Oncospace | Oncospace, Inc. | 2025 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1997 | 1 | 0 |
| 1999 | 1 | 0 |
| 2001 | 3 | 0 |
| 2002 | 1 | 0 |
| 2004 | 1 | 0 |
| 2006 | 2 | 0 |
| 2008 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2021 | 1 | 0 |
| 2023 | 1 | 0 |
| 2025 | 2 | 0 |
| 2026 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in MUJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new MUJ device
- #1 K232799 syngo.via RT Image Suitescore 18.6 · 19 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K103246 | Iplan RTSummary page 4…Hybrid Surgery Analysis Common/Classification System,Planning,Radiation Therapy Treatment Name: Main Predicate Device: iPlan RT (K103246) Secondary Predicate Not applicable Device: Device classification Medical charg… | 2011 |
What descends from it? (5)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K202284 | Oncospace | 2021 | 4 |
Has anything in its family been recalled? (0 Class I)
Recalls of this device
| Date | Class | Recall | Root cause | Reason |
|---|---|---|---|---|
| Mar 11, 2019 | Class II | Z-1205-2019 | Device Design | There is a potential for an incorrect dose distribution calculation by Brainlab RT Elements software (for affected versions) under specific circumstances when using the Pencil Beam algorithm on the GPU (graphics card), as is the default… |
| Nov 5, 2015 | Class II | Z-0647-2016 | Software design | Large objects with fine resolution are potentially displayed cropped when imported into Brainlab Brain Metastases 1.0.0. |
| Nov 5, 2015 | Class II | Z-0648-2016 | Software design | Large objects with fine resolution are potentially displayed cropped when imported into Adaptive Hybrid Surgery Analysis version 1.0.0 |
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 22 years and passes through 2 companies; a new generation was cleared every 3.5 years on median.
- 5 of the 16 ancestors have a recall of any class.
- Of its descendants, K202284 (Oncospace, Inc., 2021) has gone furthest, with 4 descendants of its own.
- 2 other devices also cite its predicate K103246.
How does its category compare?
All MUJ devicesMUJ System, Planning, Radiation Therapy Treatment: FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.
FDA decisions per year · MUJ
10in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · MUJ
186in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · MUJ
2in 2023
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · MUJ
21in 2025
MAUDE reports naming product code MUJ, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 4 | 67 | 4 | 24 |
| 2008 | 9 | 63 | 10 | 51 |
| 2009 | 16 | 84 | 11 | 24 |
| 2010 | 11 | 56 | 23 | 78 |
| 2011 | 9 | 103 | 17 | 73 |
| 2012 | 8 | 59 | 4 | 39 |
| 2013 | 5 | 64 | 6 | 33 |
| 2014 | 9 | 108 | 2 | 35 |
| 2015 | 13 | 78 | 7 | 30 |
| 2016 | 5 | 80 | 13 | 27 |
| 2017 | 7 | 30 | 4 | 16 |
| 2018 | 7 | 53 | 3 | 25 |
| 2019 | 9 | 56 | 4 | 25 |
| 2020 | 9 | 104 | 2 | 26 |
| 2021 | 11 | 87 | 4 | 15 |
| 2022 | 8 | 168 | 3 | 22 |
| 2023 | 10 | 140 | 2 | 76 |
| 2024 | 9 | 122 | 0 | 9 |
| 2025 | 10 | 186 | 0 | 21 |
| 2026 | 9 | 233 | 2 | — |
What is it indicated for?
The RT Elements are applications for radiation treatment planning for use in stereotactic, conformal, computer planned, Linac based radiation treatment of cranial, head and neck, and extracranial lesions. The “Dose Review” application as one RT Element contains features for review of isodose lines, review of DVHs, dose comparison and dose summation. The “Brain Metastases” application as one RT Element provides optimized planning and display for cranial…
Read the full statement (104 words)
The RT Elements are applications for radiation treatment planning for use in stereotactic, conformal, computer planned, Linac based radiation treatment of cranial, head and neck, and extracranial lesions.
The “Dose Review” application as one RT Element contains features for review of isodose lines, review of DVHs, dose comparison and dose summation.
The “Brain Metastases” application as one RT Element provides optimized planning and display for cranial multi-metastases radiation treatment planning.
The “Adaptive Hybrid Surgery Analysis” application as one RT Element simulates an automated template-based radiation treatment plan. The simulated plan is intended for treatment evaluation for example in tumor board meetings or operating rooms.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K142108 · printed Nov 6, 2026
Cite this page
510(k) Report. “K142108: RT Elements, Dose Review, Brain Metastases, Adaptive Hybrid Surgery Analysis.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K142108
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026